Hepatitis C virus infection and outcome of renal transplantation

E Ridruejo1, A Cusumano, C Diaz

  • 1Hepatology Section, Department of Medicine, Centro de Educación Médica e Investigaciones Clinicas Norberto Quirno, CEMIC, Buenos Aires, Argentina. eridruejo@cemic.edu.ar

Transplantation Proceedings
|December 20, 2007
PubMed

Insights

Hepatitis C virus (HCV) infection significantly reduces graft and patient survival rates in renal transplant recipients. Early identification and management of HCV are crucial for improving outcomes in kidney transplant patients.

Area of Science:

  • Nephrology
  • Hepatology
  • Transplantation immunology

Background:

  • Chronic hepatitis B (HBV) and C (HCV) viruses are prevalent in renal transplant recipients.
  • The impact of HBV and HCV on graft and patient survival post-transplantation remains debated.

Purpose of the Study:

  • To investigate the influence of anti-HCV status and other factors on graft and patient survival in renal transplant patients.
  • To determine the independent predictors of graft and patient survival in a cohort of renal transplant recipients.

Main Methods:

  • Retrospective analysis of renal transplant recipients between 1991 and 2004.
  • Evaluation of factors including anti-HCV status, age, rejection episodes, and immunosuppressive therapy.
  • Univariate and multivariate analyses to assess impact on graft and patient survival.

Main Results:

  • Anti-HCV-positive status was associated with significantly reduced graft survival (56% vs. 75%) and patient survival (68% vs. 83%).
  • Acute rejection episodes and three-drug immunosuppressive therapy also diminished graft survival.
  • Advanced age, cadaveric donor, kidney-pancreas transplantation, and three-drug immunosuppressive therapy were linked to reduced patient survival.

Conclusions:

  • Hepatitis C virus infection is a significant negative prognostic factor for both graft and patient survival after renal transplantation.
  • Minimizing immunosuppression and managing acute rejection are critical for improving outcomes in HCV-positive renal transplant recipients.

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...